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Aluminum is a weak agonist for the calcium-sensing receptor. suppressed parathyroid hormone secretion, bone dis-
Background. Aluminum (Al31) has diverse biological ef- ease, anemia, and central nervous system dysfunction in
fects mediated through activation of a putative extracellular end-stage renal failure [2, 3]. Al31 is also considered acation-sensing receptor. A recently identified calcium-sensing
possible etiologic factor in Alzheimer’s disease in the set-receptor (CaSR), which has been identified in target tissues
ting of normal renal function [4]. Different effects of Al31for Al31, may transduce some of the biological effects of Al31.
Methods. To test this possibility, we transfected human em- have been observed in experimental settings. In animal
bryonic kidney 293 (HEK 293) cells with a cDNA encoding studies, Al31 administered systemically achieves serum
the rat CaSR and evaluated CaSR expression by Western blot concentrations in the range of 50 mm [6]. At these levels,analysis and function by measurement of intracellular calcium
Al31 stimulates osteoblast-mediated de novo bone for-([Ca21]i) levels and inositol monophosphate (IP1) generation
mation in vivo and osteoblast proliferation in vitro [6–8].following stimulation with Al31 and a panel of CaSR agonists.
Results. The CaSR protein was detected by immunoblot In addition, micromolar concentrations of Al31 added to
analysis in cells transfected with the CaSR cDNA but not in various culture systems dramatically modify cellular func-
nontransfected HEK 293 cells. In addition, [Ca21]i levels and tion, including stimulation of protein kinase C (PKC)IP1 generation were enhanced in a dose-dependent fashion by
activity and suppression of agonist-induced cAMP produc-additions of the CaSR agonists calcium (Ca21), magnesium
(Mg21), gadolinium (Gd31), and neomycin only in cells trans- tion in osteoblasts [7–9] and inhibition of the glutamate-
fected with CaSR. To determine if Al31 activated CaSR, we nitric oxide synthase-cGMP pathway in neuroneal cells
stimulated cells transfected with rat CaSR with 10 mm to 1 mm [5]. A much higher Al31 concentration over the range
concentrations of Al31. Concentrations of Al31 in the range of
of 0.5 to 2.0 mm suppresses parathyroid hormone (PTH)10 mm to 100 mm had no effect on [Ca21]i levels or IP1 genera-
secretion from parathyroid cells in culture [10]. Thesetion. In contrast, 1 mm Al31 induced small but significant in-
creases in both parameters. Whereas Gd31 antagonized cal- findings support a direct and dose-dependent effect of
cium-mediated activation of CaSR, pretreatment with Al31 Al31 on certain cell types, including parathyroid chief
failed to block subsequent activation of rat CaSR by Ca21, cells, osteoblasts, and neurons. The mechanism wherebysuggesting a distinct mechanism of Al31 action.
Al31 exerts these diverse biological effects is not clear.Conclusion. Al31 is not a potent agonist for CaSR. Because
Recently a G-protein–coupled calcium-sensing recep-Al31 affects a variety of target tissues at micromolar concentra-
tions, it seems unlikely that CaSR mediates these cellular ac- tor (CaSR) was identified in parathyroid chief cells [11],
tions of Al31. as well as in a variety of other tissues [12–15]. The cDNA
for CaSR encodes a seven-transmembrane–spanning 120
kDa protein that is coupled via both pertussis toxin-
Although aluminum (Al31) is present in only trace sensitive and -insensitive G proteins to inhibition of
amounts in most biological systems [1], this trivalent cAMP accumulation and stimulation of phospholipase
cation accumulates in certain disease states such as end- C (PLC) [11]. This cation-sensing receptor is activated by
stage renal disease [2–4]. In normal cases, serum levels polyvalent cations with characteristic relative potencies,
of Al31 are typically less than 0.4 mm, whereas Al31 con- including gadolinium (Gd31, EC50 5 20 mm), neomycin
centrations often exceed 5 mm in patients with end-stage (EC50 5 60 mm), calcium (Ca21, EC50 5 3 mm), and
renal disease undergoing hemodialysis therapy [5]. Such magnesium (Mg21, EC50 5 10 mm).
Al31 accumulation is implicated in the pathogenesis of There is indirect evidence to suggest that some of the
cellular effects of Al31 are mediated by this or a closely
related extracellular cation-sensing receptor. First, CaSRKey words: agonist, human embryonic kidney cells, g-protein coupled
receptors, intracellular calcium, cations, end-stage renal disease. is expressed in many of the tissues that are targets of Al31
effects, including parathyroid [11], brain [13], and boneReceived for publication September 1, 1998
marrow [15]. Second, Al31 mimics the effects of some CaSRand in revised form December 29, 1998
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cAMP production in certain cell culture systems [7, 8, 16]. Immunoblotting
In addition, the proliferative action of Al31 on osteoblasts Membrane proteins were prepared for the culture cell
is mediated through an extracellular effect of this cation lines using the method described by Bai et al [19]. Con-
to activate G-protein–coupled receptor-like pathways by fluent cells in 100 mm plates were rinsed twice with phos-
mechanisms independent of fluoroaluminate [7, 16, 17]. phate-buffered saline (PBS) and treated with 0.02% ethy-
To evaluate directly whether Al31 activates CaSR, we lenediamenetetraacetic acid (EDTA) in PBS at 378C for
compared the effect of Al31 with the ability of known five minutes. The detached cells were collected by cen-
ionic CaSR agonists to activate PLC and mobilize intra- trifugation and resuspended in buffer containing 50 mm
cellular calcium ([Ca21]i) in human embryonic kidney Tris-HCl, pH 7.4, 0.25 m sucrose, 1 mm ethyleneglycotetra-
293 (HEK 293) cells stably transfected with the rat CaSR. acetic acid (EGTA), 1 mm EDTA, 1 mm phenylmethy-
In contrast, with regards to the activation of CaSR by sulfonyl fluoride (PMSF), a protease inhibitor cocktail
gadolinium, neomycin, and calcium, we found that Al31 (Boehringer Mannheim, Mannheim, Germany) at 48C.
was only a weak agonist for CaSR, achieving minimal After sonication, nuclei and cell debris were removed
activation of the receptor at concentrations in excess of by low-speed centrifugation (10,000 r.p.m., 10 min) at
that required for its biological effects. These data suggest 48C. The supernatant material was centrifuged at 30,000
that a different molecular mechanism is involved in me- r.p.m. for 30 minutes in a TLA-100 centrifuge at 48C to
diating the extracellular responses to micromolar con- collect the crude membrane proteins pellet. The mem-
centrations of Al31. brane proteins were solubilized with a buffer containing
1% sodium dodecyl sulfate (SDS), 10 mm Tris-HCl (pH
7.4) with freshly added protease inhibitors (1 mm PMSF,METHODS
protease inhibitor cocktail). The protein content of eachCreation of vectors for expressing rat
sample was determined by the NanoOrange Proteincalcium-sensing receptor
Quantitation Kit (Molecular Probes, Eugene, OR, USA).
The rat CaSR cDNA was obtained from Drs. Snow- All membrane protein extracts were stored at –708C.
man and Snyder [13]. To permit G418 selection of stable
Membrane proteins were separated on 6% SDS-poly-
transfectants, a BamHI fragment containing the entire
acrylamide gel. Separated proteins were transferred toCaSR coding sequence was subcloned into the mamma-
nitrocellulose membrane (0.45 mm; Bio-Rad, Richmond,lian expression vector pcDNA 3 (Invitrogen, San Diego,
CA, USA) over a 30-minute period at room temperatureCA, USA). The orientation and the nucleotide sequence
using a Milliblot semidry transfer apparatus (2.5 mA/of CaSR were confirmed by sequencing both the 59 and
cm2; Millipore, Bedford, MA, USA) according to the39 ends of the insert.
manufacturer’s recommendations. To detect rat CaSR,
we used a mouse monoclonal antibody raised to the pep-Culture and transfection of human embryonic
tide corresponding to amino acids 214 to 236 of the hu-kidney 293 cells
man CaSR (called ADD) made by Drs. Allen SpiegelHuman embryonic kidney (HEK) 293 cells were ob-
and Paul Goldsmith [20] and generously supplied by NPStained from American Type Culture Collection (Rock-
Pharmaceuticals (Salt Lake City, UT, USA). Immuno-ville, MD, USA). Cells were grown in Dulbecco’s modi-
blotting was performed by incubating blots for 60 minutesfied Eagle medium (DMEM) supplemented with 10%
at room temperature with SuperBlock (TBS) Blockingheat-inactivated fetal calf serum, penicillin (100 U/ml),
buffer (Pierce, Rockford, IL, USA). After washing withand streptomycin (100 mg/ml; all from GIBCO, Gaithers-
1 3 TBS containing 0.1% Tween-20 (TBST) for one hour,burg, MD, USA) at 378C in a humidified atmosphere of
blots were incubated with 1 mg/ml of the ADD antibody95% air and 5% CO2. HEK 293 cells were subcultured
(1:1000) overnight at room temperature. Blots wereevery week after becoming confluent using 0.25% trypsin
washed with TBST for 60 minutes and incubated with anwith 1 mm ethylenediaminetetraacetic acid (EDTA;
antimouse Ig, horseradish peroxidase-linked whole anti-GIBCO). Cell viability was assessed by standard dye
body (Amersham, Little Chalfont, Buckinghamshire, UK)exclusion techniques (0.1% trypan blue) and was always
for 60 minutes at room temperature at a dilution ofgreater than 95%. To create cell lines stably expressing
1:2500. After washes with TBST, immunoreactivity wasrat CaSR, our pcDNA 3.0 expression vector containing
detected by an Western blot chemiluminescence systemCaSR or the pcDNA 3.0 vector was transfected into
(NENe Life Science Products, Boston, MA, USA).HEK cells by the calcium-phosphate method [18]. To
enrich the population expressing rat CaSR, G418-resis-
Signal transductiontant cells were selected in complete medium containing
Measurement of inositol phosphate generation. Poly-800 mg/ml G418. Following G418 selection, HEK 293
valent cations at various concentrations were added tocells were evaluated for CaSR expression and function
as described later here. cell cultures at the specified times indicated later here.
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Al31 chloride (AlCl3 · 6 H20) was obtained from Fisher Prospect, IL, USA) and were quantitated by liquid scin-
tillation counting. Using this method, radioactivity recov-(Fair Lawn, NJ, USA). Gadolinium chloride hexahy-
ered in the IP3, IP2, and IP1 eluate fractions typicallydrate was purchased from Aldrich Chemical Co. (Milwau-
averaged 7, 5, and 88% of the total radioactivity recov-kee, WI, USA). Calcium chloride anhydrous, neomycin
ered in all eluate fractions, respectively.sulfate, were purchased from Sigma Chemical Company
(St. Louis, MO, USA). Briefly, HEK 293 cells were
Cytosolic calcium measurementsplated at a density 2 to 5 3 105 cells/ml in six-well plastic
Intracellular calcium levels ([Ca21]i) were measuredculture dishes (9.5 cm2/well; Costar, Cambridge, MA,
in confluent HEK 293 cells by fluorescence excitation ofUSA). After reaching confluence, cells were equilibrated
cells loaded with the fluorescent probe fura-2 as pre-for 24 hours in DMEM low inositol medium (GIBCO)
viously described [21]. Cells were grown on plastic Aclarwith 0.1% dialyzed fetal calf serum (FCS), penicillin (100
cover slips (Pro Plastics, Linden, NJ, USA) until conflu-U/ml), and streptomycin (100 mg/ml; all from GIBCO)
ence and were then incubated for an additional day incontaining 5 mCi/ml myo-[3H]-inositol (New England
DMEM with 0.1% FCS and antibiotics. Cells wereNuclear, Boston, MA, USA). The cultures were washed
loaded for one hour in DMEM with fura 2 acetoxymethylthree times with 2 ml of buffer solution containing 20
ester (fura 2-AM; Sigma) added to the culture mediummm HEPES, 125 mm NaCl, 4 mm KCl, 0.5 mm CaCl2,
to a final concentration of 5 mm. Cells were then washed0.5 mm MgSO4, and 0.1% dextrose, pH 7.4. Ionized cal-
at 378C with a buffer solution containing 20 mm HEPES,cium and pH were measured after the addition of the
125 mm NaCl, 4 mm KCl, 0.5 mm CaCl2, 0.5 mm MgSO4,cations using an ion detection electrode (AVL; Omni
1 mm NaH2PO4, and 0.1% dextrose, pH 7.4, without furaModular System, AUL Medical Instruments, Schaff-
2-AM. After washing, cover slips were inserted diago-hausen, Switzerland). For studies involving IP measure-
nally into curvette and were continuously perfused withments, cells were then incubated for the indicated times
the same buffer solution. To insure adequate loadingwith the agents to be tested or their vehicle in 2 ml buffer
and complete hydrolysis of the methylester, emissionsolution at 378C containing 20 mm lithium chloride. Lith-
was measured at 510 nm over the excitation spectrumium chloride was included in the incubation medium to
from 300 to 400 nm with a Perkin-Elmer LS50 fluores-inhibit breakdown of IPs. IPs were measured as pre-
cence spectrometer (Perkin-Elmer, Norwalk, CT, USA).viously described using anion exchange chromatography
Real-time measurements were monitored by alternating[21]. After stimulation with the various cations, the reac-
the excitation wavelength between 340 and 380 nm everytion was stopped by aspirating the medium, adding 240
1.9 seconds with a microcomputer, and data were derived
ml of 3.3 N perchloric acid, and then placing the samples from the ratio of emission at 510 nm. [Ca21]i was calcu-on ice. After 15 minutes, cell monolayers were scraped lated as described by Grynkiewicz [22] using the follow-
off with a plastic spatula and transferred to a plastic ing formula:
microcentrifuge tube. The wells were washed with an
additional 960 ml of 0.55 N perchloric acid, and this Ca21 5 KD
(R2Rmin) Sf2
(Rmax2R) Sb2rinse pooled with the initial 240 ml wash. Samples were
centrifuged for five minutes at 10,000 3 g, and exactly
KD is the dissociation constant of the Ca21-fura 2 com-1 ml of supernatant was transferred to another microcen- plex, and 224 nm was employed in these calculations [22].
trifuge tube. One milliliter of supernatant was neutral- R is the fluorescence emission ratio derived by dividing
ized by adding 55 ml of 10 N KOH and placing the the fluorescence at an excitation wavelength at 340 nm
samples on ice. After 15 minutes, neutralized samples by the fluorescence excitation wavelength at 380 nm. Sf2were centrifuged at 10,000 3 g for five minutes. For and Sb2 are the fluorescence at an excitation wavelength
chromatography, 0.9 ml of supernatant was added to 9 ml of 380 nm for Ca21-free dye (Sf2) and for Ca21-bound
of 5 mm sodium borate and applied to 1.0 ml columns dye (Sb2). Rmax and Rmin are the maximal and minimal
packed with AG1-X8 formate anion exchange resin (Bio- fluorescence emission ratios, respectively. Rmax and Sb2
Rad). Columns were washed twice with 10 ml of 5 mm were experimentally determined at 378C using 1 mm fura
sodium tetraborate containing 60 mm ammonium for- 2 dissolved in a solution of the following composition
mate, and IPs were eluted sequentially with 3.5 ml of designed to mimic intracellular ionic conditions: 115 mm
0.1 m formic acid containing either 0.2 m, 0.4 m, or 1.0 m KCl, 20 mm NaCl, 1 mm MgCl2, 10 mm HEPES, 2 mm
ammonium formate for inositol monophosphates (IP1), CaCl2, pH 7.1. This solution was supplemented with 10
inositol bisphosphates (IP2), and inositol trisphosphates mm EGTA to obtain Rmin and Sf2.
(IP3), respectively. Columns were washed with 10 ml
Statistical analysisvolumes of the appropriate elution buffer between col-
lections of eluate fractions to remove any residual radio- Data are presented as the mean 6 se of the mean.
activity. Eluate fractions were dissolved in 17 ml of Statistical significance was assessed using a paired or
unpaired t-test as indicated.Safety-Solve (Research Products International, Mount
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smaller bands that have been observed by immunoblot
analysis in other cells and tissues [20, 24]. These data
are consistent with the absence of an endogenous CaSR
protein in wild-type HEK 293 cells and the presence of
high levels of exogenous CaSR protein in HEK 293 cells
transfected with the CaSR cDNA.
Cation-induced increases in [Ca21]i and inositol
phosphate generation in HEK 293 cells transfected
with CaSR
Figure 2 shows the effects of extracellular calcium on
[Ca21]i levels in HEK 293 cells stably expressing CaSR.
We found that extracellular calcium concentrations
above 2 mm were required to elicit an increase in [Ca21]i
levels. A maximal response was obtained at extracellular
calcium concentrations of 10 mm. In contrast, increasing
extracellular calcium levels failed to elicit an increase in
[Ca21]i in nontransfected cells (Fig. 2B) or cells stably
transfected with vector not containing CaSR (data not
shown). To assess the response to other CaSR agonists,
we examined the effects of gadolinium, neomycin, and
magnesium on [Ca21]i levels in HEK 293 cells with and
without CaSR (Fig. 3). Gadolinium, neomycin, and mag-
nesium, at concentrations known to activate CaSR in
Fig. 1. Western blot analysis of calcium sensing receptor (CaSR) ex- other systems [11], resulted in similar increments inpression in human embryonic kidney (HEK) 293 cells. Expression of
[Ca21]i concentrations (Fig. 3). No response to these ago-rat CaSR was assessed by Western blotting, as described in the Methods
section, in human parathyroid tissue (lane 1), in HEK 293 cells stably nists was detected in nontransfected HEK or cells stably
transfected with the CaSR cDNA (lane 2), and in nontransfected HEK transfected with vector not containing CaSR (data not293 cells (lane 3). We detected three major bands of apparent molecular
shown). These data suggest that transfection of CaSRmass of 140, 165, and 250 kDa in membrane protein preparations from
HEK 293 transfected with CaSR cDNA. These bands were not observed cDNA confers a functional response to extracellular cat-
in nontransfected HEK 293 cells. The 250 and 165 kDa bands predomi- ions in HEK 293 cells.nated in human parathyroid tissue.
We next examined the effects of extracellular cations
on IP1 generation in HEK 293 cells stably expressing
rat CaSR. As shown in Table 1, IP1 generation was en-
hanced in HEK 293 cells stably expressing rat CaSR fol-RESULTS
lowing the addition of calcium, gadolinium, neomycin,Expression of rat calcium-sensing receptor in human
and magnesium to the extracellular fluid at concentrationsembryonic kidney 293 cells
known to activate CaSR in other model systems [11].
Figure 1 shows the expression of rat CaSR in cells Addition of this same panel of cations to control cells
stably transfected with the CaSR cDNA compared with did not significantly enhance PI hydrolysis (Table 1). At
nontransfected HEK 293 cells. We detected three major the concentrations tested, the absolute magnitude to the
bands with apparent molecular masses of 140, 165, and IP1 response was less with gadolinium and neomycin
250 kDa in membrane protein preparations from HEK compared with calcium, as has been observed by other
293 cells transfected with CaSR cDNA (lane 2), which investigators [11, 24, 25]. These data suggest that the
are similar to those observed in human parathyroid tissue CaSR is coupled to PLC in HEK 293 cells, and the
(lane 1). These bands were not observed in nontrans- pattern of PLC activation induced by calcium, magne-
fected HEK 293 cells (Fig. 1, lane 3) or HEK cells trans- sium, gadolinium, and neomycin is similar to the pattern
fected with the vector not containing CaSR (data not reported by other investigators.
shown). The 140 and 165 kDa bands may be caused by
Aluminum-induced increases in [Ca21]i and inositoldifferential degrees of glycosylation, proteolytic frag-
phosphate generation in HEK 293 cells transfectedmentation arising during purification, or the presence
with CaSRof alternatively spliced products as reported by other
investigators [20]. The 250 kDa band may represent ag- Figure 4 compares IP1 generation induced by calcium
gregated or dimerized receptor and has also been de- (Fig. 4A) and Al31 (Fig. 4B) in HEK 293 cells stably
transfected with rat CaSR. PI hydrolysis was enhanced,scribed by other investigators [23]. We did not detect
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Fig. 2. Effects of extracellular calcium on
[Ca21]i levels in HEK 293 cells. Calcium-induced
activation of rat CaSR was assessed by moni-
toring [Ca21]i levels using fura 2-loaded cells
as described in the Methods section. (A) Results
for HEK 293 cells stably expressing the CaSR.
(B) Results in nontransfected HEK 293 cells.
Extracellular calcium concentrations above
2 mm were required to elicit an increase in
[Ca21]i levels in cells transfected with CaSR. A
maximal response was obtained at extracellular
calcium concentrations of 10 mm. In contrast,
increasing the extracellular calcium concen-
tration did not enhance [Ca21]i levels in non-
transfected cells, although the addition of the
calcium ionophore ionomycin caused a rapid
increase in [Ca21]i levels. Results are represen-
tative of three to six separate experiments.
in a dose-dependent fashion, by additions of calcium cells or HEK cells transfected with the vector not con-
taining CaSR (data not shown).between 3 and 20 mm to the extracellular fluid. The EC50
value for this response was approximately 4 mm, which Because Al31 has the potential to lower pH and possi-
bly alter the ionized calcium concentrations, we per-is comparable to the EC50 value reported for calcium by
other investigators [11, 24, 25]. Additions of Al31 to the formed additional studies to exclude indirect effects of
Al31 on the IP response. In this regard, we found that theextracellular fluid also caused a dose-dependent increase
in IP1 generation (Fig. 4B). At the 0.5 and 1 mm concen- addition of Al31 resulted in a concentration-dependent
reduction in pH from 7.24 at 25 mm to a pH of 6.90 attrations, Al31 induced significant increases in IP1 genera-
tion in HEK 293 cells transfected with rat CaSR. The 1 mm Al31 chloride. Because the buffer lacked albumin
and phosphate, there were no changes in ionized calciummagnitude of the IP response induced by 1 mm Al31,
however, was approximately 10% of the maximal re- after the addition of Al31 to the media. The ionized
calcium in the media was 0.5 mm before and after thesponse induced by calcium (compare Fig. 4 A and B).
Because of decreased solubility at higher concentrations, addition of Al31 chloride. Nevertheless, we examined
the effects of pH reduction on IP generation in HEKwe were unable to evaluate concentrations of Al31 above
1 mm adequately. More importantly, no significant in- cells expressing CaSR. We found that pH reductions
from 7.4 to 6.8 had minimal effects on IP1 generationcrease in IP1 generation was detected at the 10, 25, or
100 mm concentrations of Al31, which have been shown (data not shown). Moreover, we demonstrated the per-
sistence of Al31-stimulated IP1 generation after correct-to activate a putative G-protein receptor-like mechanism
in osteoblasts [26]. Similarly, no increase in Al31-induced ing the pH of the media to 7.4 (data not shown).
Figure 5 compares the effects of the trivalent cationsPI hydrolysis was detected in nontransfected HEK 293
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Table 1. Cation-induced IP1 generation
Cells tranfected with RCaR Control cellsa
Compound % increase above baseline
CaCl2 10 mm 19566293 22 64
MgCl2 10 mm 11106420 23 613
GdCl3 1 mm 292649b 1266
Neomycin 1 mm 270690b 060
There were 2–8 experiments per compound. Values are the mean 6 sem.
a Control cells are either non-transfected HEK 293 cells or HEK 293 cells
transfected with vector not containing CaSR (results were similar for either type
of control)
b P , 0.05 vs. calcium
biological effects of Al31 at low micromolar concentra-
tions [16, 26–28].
Pretreatment with Al31 did not prevent the subsequent
activation of CaSR by extracellular calcium (Fig. 5A).
In contrast, pretreatment with gadolinium prevented sub-
sequent calcium-induced increases in [Ca21]i in HEK 293
cells transfected with CaSR (Fig. 5B). Whether this ap-
parent loss of receptor responsiveness induced by gado-
linium represents gadolinium blockade of calcium bind-
ing to the receptor, down-regulation of CaSR receptor
or other actions of gadolinium to modulate G-protein–
coupled receptor function requires further study. Never-
theless, these results suggest that high-dose Al31 effects
on CaSR may be mediated by a mechanism distinct from
gadolinium.
DISCUSSION
There is compelling evidence suggesting that extracel-
lular Al31 cation at micromolar concentrations activates
a G-protein–coupled receptor-like signaling pathway in
certain cells by a mechanism independent of its known
effects to facilitate fluoride activation of G proteins [17,
Fig. 3. Effects of CaSR agonists on [Ca21]i levels in HEK 293 trans- 26]. The overlapping cation specificity of the Al31 responsefected with rat CaSR. The ability of CaSR agonists to activate rat CaSR
was assessed by monitoring [Ca21]i levels following the addition of with that of CaSR agonists calcium, gadolinium, and
gadolinium (A), neomycin (B), or magnesium (C) to the extracellular neomycin suggests that CaSR may mediate the response
fluid using fura 2-loaded cells, as described in the Methods section.
to Al31 in some cell systems. Therefore, we performedAdditions of gadolinium, neomycin, and magnesium at the indicated
concentrations caused similar increments in [Ca21]i levels in HEK 293 the current studies to determine if Al31 is an agonist for
cells transfected with rat CaSR. Results are representative of four to the known CaSR. We found that Al31 did not activate
six separate experiments per compound.
CaSR at bioactive micromolar concentrations (Figs. 4
and 5). With the possible exception of the effect of milli-
molar Al31 suppressing PTH secretion in isolated para-
thyroid cell cultures [9], the concentrations of Al31 re-Al31 (Fig. 5A) and gadolinium (Fig. 5B) on [Ca21]i levels
quired to activate CaSR in HEK 293 cells greatly exceedin cells transfected with rat CaSR. Al31 concentrations
those needed to stimulate a putative cation-sensing mech-of 1 mm caused a small increment in [Ca21]i levels. This
anism in other model systems [16, 27, 28]. In this regard,response to Al31 was dependent on the presence of CaSR,
micromolar concentrations of extracellular Al31 stimu-because nontransfected HEK control cells failed to re-
late a cell proliferative response in a variety of cell linesspond to Al31 at any of the tested doses (data not shown).
[16, 27, 28], as well as inhibit agonist-induced adenylylWhereas millimolar concentrations of Al31 activated the
cyclase activity and induce a PKC-dependent inductionCaSR, we were unable to demonstrate Al31-induced acti-
of the serum response promoter element in MC3T3-E1vation of rat CaSR at concentrations of Al31 between 10
and 100 mm, despite previous work that has demonstrated osteoblasts [8, 16]. Our findings are consistent with other
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Fig. 5. Comparison of aluminum and gadolinium effects on [Ca21]i
levels in HEK 293 cells transfected with rat CaSR. The ability of alumi-
num (A) and gadolinium (B) to increase [Ca21]i was assessed by monitor-
ing [Ca21]i levels following the addition of the trivalent cations to the
extracellular fluid using fura 2-loaded cells as described in the Methods
section. Additions of 10 or 100 mm aluminum did not cause an increase
in [Ca21]i levels. At 1 mm aluminum, a small increment in [Ca21]i was
observed that did not prevent the subsequent activation of CaSR by
extracellular calcium. In contrast, the addition of 50 mm gadolinium to
the extracellular fluid caused an increase in [Ca21]i levels and blocked
subsequent calcium-induced increases in [Ca21]i levels. Results are rep-
resentative of four to six separate experiments per compound.
293 cells as measured by PI-PLC activation. In this re-
Fig. 4. Effects of cations on inositol monophosphate (IP1) generation gard, demonstrable activation of CaSR occurred in the
in HEK 293 cells transfected with rat CaSR. IP1 generation was mea- millimolar range (Figs. 4 and 5). Even at these high
sured as described in the Methods section 30 minutes after the addition
concentrations, the increments in [Ca21]i levels and PIof calcium (A) or aluminum (B) to the extracellular fluid. PI hydrolysis
was enhanced, in a dose-dependent fashion, by additions of calcium hydrolysis in response to Al31 were small in comparison
between 3 and 20 mm. Aluminum also caused a modest increase in IP1 to all other CaSR agonists tested (Fig. 4). We did not
generation at the 0.5 and 1 mm concentrations. No significant increase
test to see if additional stimulation of CaSR occurred atin IP1 generation was detected at the 10, 25, or 100 mm concentrations
of aluminum. Values are the mean 6 sem of three separate determina- even higher concentrations because the limited solubility
tions. The asterisk indicates a significant difference at P , 0.05 vs. 2 of Al31 makes such studies difficult to perform. Never-
mm calcium (A) or vs. 10 mm aluminum (B).
theless, it is likely that Al31 acts as a partial agonist for
CaSR, although we cannot exclude the possibility that
the observed effect of high-dose Al31 may represent a
nonspecific effect on this cation receptor. In spite ofrecent studies demonstrating no effect of Al31 at concen-
aluminum’s ability to activate CaSR at high concentra-trations between 1 and 100 mm on IP production in
tions, it failed to reproduce the effect of gadolinium andCCL39 fibroblasts transfected with CaSR [25]. These
calcium on CaSR (Fig. 5). Indeed, Al31 failed to blockdata suggest that the known CaSR does not transduce
subsequent CaSR activation by calcium, whereas pre-the biologically important actions of Al31.
treatment with the CaSR agonist gadolinium successfullyWe did find, however, that pharmacological concentra-
tions of Al31 weakly activate CaSR transfected into HEK blocked the ability of calcium to activate CaSR. This
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Arthritis and Musculoskeletal and Skin Diseases (L.D.Q.), and R29-inability to mimic the effect of other agonists suggests
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